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CHAPTER 1 
INTRODUCTION 
 
 Although synapse stability and maintenance are very important for the maturation 
and continuous function of a synapse, a thorough understanding of the underlying 
mechanisms and contributing factors still remains unclear. The neuromuscular junction 
is a highly specialized synaptic structure for the transmission of an electrical impulse 
from the motor neuron to a skeletal muscle fiber (Figure 1A). Motor neurons, whose 
cell bodies are located in the ventral horn of the spinal cord, extend myelinated axons 
that arborize into fine unmyelinated branches when they reach target muscle fibers. 
Each motor neuron can innervate multiple muscle fibers (Dale et al., 2005), but each 
muscle fiber receives inputs from only one motor neuron resulting in only one 
neuromuscular junction for each muscle fiber. A neuromuscular junction consists of 
four physical components: the presynaptic nerve terminal with capping perisynaptic 
Schwann cells (PSCs), the synaptic basal lamina occupying the synaptic cleft, and the 
postsynaptic muscle fiber (Hughes et al., 2006).  
 The frog neuromuscular junction is a useful system for studying synapse stability 
and function. It has highly specialized cellular and molecular structure (Figure 1B). At 
the adult frog neuromuscular junction, release sites of the motor nerve terminal are 
characterized by clusters of synaptic vesicles, active zones, and the molecular 
machinery for neurotransmitter release.  These release sites are separated by nonrelease 
domains and are distributed at 1µm intervals along the length of motor nerve terminal. 
Presynaptic release sites are precisely apposed by junctional folds in the muscle 
membrane where concentrations of acetylcholine receptors (AChR) are found (Kuffler 
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and Yoshikami, 1975). The presynaptic motor nerve terminal is capped by 1-12 
nonmyelinating PSCs (Frietas and Connor, unpublished results). PSCs occasionally 
project thin cytoplasmic extensions that encircle nerve terminals in nonrelease domains. 
The synaptic basal lamina, a network of extracellular matrix molecules including Type 
IV collagen, laminin and heparan sulfate proteoglycan, lies in the synaptic cleft and is 
an extension of the basal laminae of PSCs and the muscle fiber. The coordinated 
maintenance of all synaptic components is required for stable and effective synaptic 
transmission. Here, I will focus on the mechanisms of the maintenance of the nerve 
terminal organization. 
 Studies from mammalian neuromuscular junctions have suggested that retrograde 
factors from muscle fibers are vital for the stability of motor nerve terminals. Segments 
of nerve terminal branches retracted rapidly after blockade of AChRs or removal of 
muscle fibers (Balice-Gordon and Lichtman, 1994; Rich and Lichtman, 1989). Our lab 
has previously assayed the role of the target muscle fiber in the stabilization and 
maintenance of frog motor nerve terminals by analyzing target-deprived nerve terminals 
using repeated in vivo imaging. The results showed that the nerve terminals were well 
maintained functionally and structurally during the first two months after target loss, 
suggesting that nonmuscle factors play a role in the stabilization of nerve terminals 
(Dunaevsky and Connor, 1998). 
 Several lines of evidence point to a dynamic role of the PSCs in the function of the 
neuromuscular junction including the stability of motor nerve terminal. PSCs possess 
neurotransmitter receptors and ion channels, allowing them to sense synaptic activity 
and respond by increasing the intracellular concentration of calcium (Verkhratsky and 
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Steinhause, 2000; Rochon et al., 2001). This Ca2+ increase can reciprocally effect 
synaptic transmission; blocking Ca2+ increase in PSCs prevented the potentiation of 
transmitter release (Castonguay and Robitaille, 2001). These results demonstrated that 
PSCs contribute to short-term regulation of neurotransmission.  PSCs can also respond 
to nerve injury by sprouting. These sprouts precede and guide nerve growth (Koriala et 
al., 2000; Kang et al., 2003; Hayworth et al., 2006). In knockout mice that lack 
Schwann cells, neuromuscular junctions could be transiently formed but retracted 
within a few days (Lin et al., 2000; Wolpowitz et al., 2000). These results suggested 
that PSCs are dispensable for initial synapse formation but essential for subsequent 
synapse growth and maintenance. Further, Schwann cell processes lead sprouting motor 
axons to reinnervate neuromuscular junctions (Son et al., 1996). 
 For further examination of the role of PSCs in synaptic function, PSCs at frog 
neuromuscular junctions can be selectively ablated in vivo by complement-mediated 
cell lysis. In PSC ablation studies by Ko and colleagues, about 13% of the PSC-ablated 
neuromuscular junctions showed either partial retraction or complete loss of the nerve 
terminal as well as a decrease in presynaptic release 1 week after PSC ablation. 
However, within 1 day of the PSC ablation, defined as acute ablation, little alteration in 
either the structure or function of the nerve terminals was observed (Reddy et al., 2003). 
Therefore, neither muscle fiber removal for less than 2 months nor PSC ablation alone 
induced significant change in the structure and function of motor nerve terminals. One 
possibility is that sufficient stabilization cues are provided to nerve terminals as long as 
one synaptic partner remains, either the muscle fiber or the PSC. Alternatively, the basal 
lamina may be the important factor. To test these possibilities, one can ask how nerve 
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terminal stability is affected by loss of both target muscle fiber and associated 
perisynaptic Schwann cells.  
 The goal of my thesis is to investigate the morphology of nerve terminals deprived 
of both their target muscle fiber and associated PSCs. We combined the methods of 
microsurgery and complement-mediated PSC ablation to kill both muscle fibers and 
PSCs at frog neuromuscular junctions. Nerve terminal stability was assayed by 
immunohistochemistry using markers of the synaptic site and nerve terminal. My 
hypothesis is that both muscle fiber and PSCs contribute to the stability of motor nerve 
terminals. In their absence, I predict that the distribution of the nerve terminal marker 
will be altered compared to that observed when nerve terminals are deprived of only 
one of the synaptic members, either PSCs or muscle fibers. Data rejecting this 
hypothesis will suggest a role of synaptic basal lamina in the maintenance of motor 
nerve terminals. 
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CHAPTER 2 
METHODS 
Selective removal of muscle fibers 
 
 Cutaneous pectoris (CP) muscles of adult frogs (Rana pipiens) are located just 
beneath the skin of the thorax and are accessible for manipulation and surgical 
intervention. The muscle fibers of cutaneous pectoris muscles were damaged as 
described previously in order to cause selective muscle fiber degeneration while 
preserving the innervating axons and synaptic sites (Yao, 1988; Dunaevsky and Connor, 
1998). Briefly, careful cuts were made in nonsynaptic muscle regions of fibers to induce 
their degeneration and phagocytosis. Following muscle damage, the skin was sutured 
and the frogs recovered from anesthesia. Regeneration of muscle fibers was prevented 
by X-irradiation of the thorax for three consecutive days at the time of microsurgery 
(Dunaevsky and Connor, 1998). 
 
In vivo ablation of perisynaptic Schwann cells  
 Complement-mediated cell lysis was used to ablate PSCs as described by Reddy et 
al., 2003.  Briefly, this method uses an antibody specific for PSCs, an IgM monoclonal 
antibody, 2A12 (mAb 2A12), that recognizes the surface membrane of PSCs (Astrow et 
al.,1998). Reddy and his colleagues have demonstrated that exposure to mAb 2A12, 
followed by guinea pig complement serum, selectively kills PSCs at neuromuscular 
junctions of cutaneous pectoris muscles (Reddy et al. 2003). The 2A12 hybridoma cell 
line was provided by our collaborator, Dr. Chien-Ping Ko at the University of Southern 
California. I raised the hybridoma cells, tested the supernatant for its ability to stain 
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PSCs, and produced 2A12 ascites (see Results). Control frogs in PSC ablation 
experiments were treated with normal frog Ringer’s solution (NFR: 160mM NaCl, 
4mM KCl, 1.8mM CaCl2, 1mM NaH2PO4, pH 7.2) instead of mAb 2A12, followed by 
guinea pig complement. The ablation process was as follows:  Adult frogs (Rana 
pipiens) were anaesthetized in 0.1% MS-222 (Sigma-Aldrich, St. Louis, MO) and the 
skin over the chest of these frogs was opened. These frogs were then injected in the 
space beneath each CP muscle with ~150µl NFR solution containing mAb 2A12 ascites 
(1:7.5) (PSC-ablated frogs) or with ~150µl NFR solution alone (control frogs). After a 
three hour incubation at room temperature, frogs were then injected with guinea pig 
complement serum (2:1) diluted with distilled water and incubated for 15 minutes 
warmed to 34 oC. Undiluted guinea pig complement serum was then injected and the 
frogs were incubated for an additional 45 minutes at 34 oC. and then 1 hour on ice.  
 Immediately following the completion of the ablation process, the efficiency of the 
PSC ablation was verified by staining the muscles in situ with peanut agglutinin (PNA) 
PNA-Tritc (1:50; Sigma-Aldrich, St. Louis, MO), a marker of the synaptic and 
Schwann cell basal lamina (Ko 1987), and a membrane impermeable nuclear dye, 
ethidium homodimer (EthD; 1:5000; Invitrogen-Molecular Probes, Carlsbad, CA). In 
some experiments, the CP muscles were dissected immediately after verification of 
ablation. In other experiments, the frogs were sutured and allowed to recover after 
verification.  
 Since EthD only labels nuclei of membrane-damaged cells (Reddy et al. 2003), only 
the nuclei of successfully ablated PSCs are positively stained by EthD. In control 
preparations, the PSCs should not be damaged and the PSC nuclear space should not be 
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labeled with EthD. One week after PSC ablation process, as the ablated PSCs are 
phagocytosed, their nuclei are removed and the EthD stain is lost from ablated sites.  As 
a result, in preparations dissected 1 week after the ablation process, Hoechst33342 
nuclear stain (1:5000; Invitrogen-Molecular Probes, Carlsbad, CA) was used to stain 
nuclei of all cells.  If a synaptic site continues to be devoid of living PSCs, the PSC 
nuclear space, delineated by PNA stain, should be Hoechst33342-negative. 
  
Immunohistochemistry 
 Preparations were dissected in NFR solution in Sylgard-lined dishes, fixed with 4% 
paraformaldehyde for 30 minutes, then rinsed in a phosphate buffered solution (PBS, 
Huang et al. 1998) with  1% Triton X-100  (PBST) and incubated in blocking solution 
(BKS: 5% normal goat serum and 0.5% Triton X-100 in PBS) before incubation with 
antibodies. Presynaptic nerve terminals were identified by staining with mAb SV2 
(Developmental Hybridoma Bank, Iowa City, Iowa) that recognizes an integral 
membrane protein in synaptic vesicles (Dong et al., 2006). It is often used to stain nerve 
terminals because of its robust staining signal (Panzer, 2005). However, while MAbSV2 
stain is a marker of nerve terminal differentiation, anti-SV2 immunostaining alone is not 
sufficient to determine whether a nerve terminal has retracted or not. For example, loss 
of SV2 labeling might result from dispersion of synaptic vesicles rather than nerve 
terminal retraction. Therefore, an antibody directed against acetylated tubulin (A-tub; 
1:200, Sigma-Aldrich, St. Louis MO) was used to stain neuronal microtubules within 
the nerve terminal. Combining SV2 and A-tub stain provides information as to the 
differentiation state of the nerve terminal as well as its presence at a synaptic site. 
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Following ablation and/or surgery, synaptic sites were visualized with peanut agglutinin 
(PNA; Sigma-Aldrich, St. Louis, MO) that stains Schwann cell-associated basal lamina 
(Ko 1987). Postsynaptic acetylcholine receptors (AChRs) were labeled with rhodamine-
conjugated α-bungarotoxin (α-BTX; Sigma-Aldrich, St. Louis, MO).  
 In some control experiments, muscles or target-deprived preparations were first 
incubated with 2A12 supernatant or NFR solution prior to fixation with 4% 
paraformaldehyde for 30 minutes. MAb 2A12 only stains living synaptic sites (Astrow 
et al.,1998). Preparations were then rinsed and incubated with CY3-conjugated 
secondary antibodies (Jackson Immuno Labs). 
 After staining, preparations were mounted on glass slides with Vectashield 
mounting medium (Vector labs) and stored at -20°C until imaging. 
 
Imaging 
 Images were captured by a Zeiss meta 510 confocal microscope, and processed with 
the Zeiss LSM software and Adobe photoshop 7.0. As Hoechst33342 stain could not be 
seen in the confocal microscope. So I confirmed the ablation in the fluorescent scope 
when selecting a synaptic site for imaging. Imaging was performed at the UMASS 
Central Microscopy Facility. 
 
Quantitation 
 Preparation were dissected immediately or 7 days after ablation, processed for 
immunohistochemistry, and viewed with an epifluorescence Zeiss Axioskop 20. PNA 
stain delineated the boundaries of the synaptic site, widening at the location of PSC 
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nuclei (Ko, 1987). Synaptic sites were selected for quantitation that could be viewed in 
total. Each selected synaptic site was scored for: 1) presence of a muscle fiber; 2) 
presence of PSCs; 3) presence of a nerve terminal and 4) alignment of SV2 and PNA 
stains. The absence of muscle fiber striations in bright field microscope indicated that 
the synaptic site was target deprived. The ablation state of each synaptic site was scored 
by the presence or absence of intact PSC nuclei: PSC-ablated synaptic sites were either 
EthD positive or Hoechst negative. Only those synaptic sites where the majority of the 
PSC nuclei were EthD-positive were counted. The presence of a nerve terminal at a 
PNA-stained synaptic site was determined by anti-A-tub immunostaining and a 
differentiated nerve terminal was stained by mAb SV2. To assess nerve terminal 
stability, I compared the overlap between PNA and SV2/A-tub labeling. Absence of 
SV2/A-tub stain at a synaptic site indicated loss of the nerve terminal. 
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CHAPTER 3 
RESULTS 
SV2 as a marker of target-deprived nerve terminals 
 It has been previously observed that nerve terminals, labeled with FM1-43, a dye 
incorporated into recycled synaptic vesicles, were well retained for up to 2 months after 
muscle fiber removal (Dunaevsky and Connor, 1998). I first confirmed that SV2 is a 
reliable marker of nerve terminals at target-deprived synaptic sites. In my experiments, I 
compared SV2 staining of intact neuromuscular junctions to that of synaptic sites 
lacking muscle fibers. One to two months after muscle damage and X-irradiation, 
cutaneous pectoris muscles were dissected and triply stained with FITC-tagged PNA to 
mark synaptic sites, rhodamine-conjugated α-BTX for postsynaptic acetylcholine 
receptors (AChRs), and SV2 for presynaptic nerve terminals. As expected, at control 
synapses, PNA, SV2 and α-BTX staining were closely aligned (Figure 2, a-d). Of the 
203 synaptic sites examined, none showed mismatch between SV2 and PNA stain; the 
PNA and SV2 stains were colocalized at each synaptic site. 
 Target-deprived synaptic sites lacked muscle fiber striations and the α-BTX staining 
was mostly gone, indicating the absence of target muscle fibers (Figure 2, e-h). About 
5% of synaptic sites showed mismatch or complete absence of SV2 staining. These data 
suggest that SV2 staining is a good marker of target-deprived motor nerve terminals; 
SV2 stain occupied the space delineated by PNA stain as in controls. The nerve 
terminals were well maintained in the target-deprived synaptic sites, which is consistent 
with previous reports (Dunaevsky and Connor, 1998). The observed mismatch between 
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SV2 and PNA staining at the 5% of synaptic sites may be due to damage of axons 
during the microsurgery to remove muscle fibers (Dunaevsky and Connor, 1998). 
 
Ablation of PSCs using complement-mediated cell lysis 
 For complement-mediated cell lysis, a cell-specific IgM antibody is required that 
marks the surface of the cells to be lysed; 2A12 is such a marker for perisynaptic 
Schwann cells (Reddy et al. 2003).  I have confirmed that mAb 2A12 labels PSCs at the 
frog neuromuscular junction and can be used to successfully ablate them. Normal frog 
neuromuscular junctions have from 2-12 PSCs associated with the motor nerve terminal 
at a single synaptic site (Frietas and Connor, unpublished observations). To test the 
ability of mAb2A12 to stain PSCs, muscles were incubated with mAb 2A12 
supernatant, ascites, or normal frog Ringer’s solution followed by CY3-conjugated 
secondary antibodies. The mAb 2A12 supernatant solutions (Figure 3) and mAb 2A12 
ascites (data not shown) stained synaptic sites in a similar manner to PNA (Figure 3).  
 I next tested the effectiveness of the mAb 2A12 supernatant and ascites in ablating 
PSCs.  Following complement-mediated cell lysis using mAb 2A12, synaptic sites were 
visualized with PNA stain and compromised nuclei were identified with EthD. The 
mAb 2A12 ascites was superior to the supernatant in ablating PSCs; more synaptic sites 
were positively stained with EthD homodimer following ablation with ascites when 
compared to ablation using supernatant.  MAb 2A12 ascites successfully and selectively 
damaged PSCs in vivo. Nuclei of PSC were positively stained with EthD, indicating that 
the PSCs were compromised or dead (Figure 4). All subsequent ablations were 
performed using mAb2A12 ascites. 
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 The stability of nerve terminals was first assessed at neuromuscular junctions where 
PSCs were ablated in the presence of muscle fibers. Immediately following PSC 
ablation, cutaneous pectoris muscles were dissected and the nerve terminals were 
marked with SV2 stain. Nerve terminals stained with SV2 had normal morphology at 
acute PSC-ablated neuromuscular junctions, compared with controls (Figure 5). PSC 
nuclei in control muscles, exposed to the same protocol with the exception that mAb 
2A12 ascites was replaced with NFR, were not stained by EthD. There was no 
mismatch between SV2 and PNA at any control neuromuscular junctions while 5% of 
the acute PSC-ablated neuromuscular junctions showed partial or complete loss of SV2 
stain (Table 1).   
 I next examined intact neuromuscular junctions one week after PSC ablation. One 
week after PSC ablation, muscles were dissected and stained with SV2, PNA, and the 
membrane-permeable nuclear dye, Hoechst33342.  At ablated synaptic sites, no 
Hoechst-stained nuclei were associated with the widenings in the PNA stain. At control 
neuromuscular junctions, PSC nuclei were positively stained by Hoechst stain. At 1 
week, the frequency of mismatch between SV2 and PNA stains at PSC-ablated synaptic 
sites was increased. Mismatch or total loss of SV2 staining was seen in about 18% of 
PSC-ablated synaptic sites (Table 2). As shown in Figure 6, there was a clear mismatch 
between SV2 and PNA staining at some synaptic sites. Synaptic sites devoid of SV2 
stain frequently also were negative for A-tub stain, indicating the total retraction of the 
nerve terminal from the synaptic site.  In contrast, only 3.5% of synaptic sites showed 
any mismatch in the control group (n=141 neuromuscular junctions, 2 muscles; Table 2). 
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Stability of motor nerve terminals deprived of both PSCs and target muscle  
 To determine the factors responsible for nerve terminal stability, I assayed the 
stability of target-deprived nerve terminals immediately or one week after PSC ablation. 
The choice of one week for analysis is directed by the observation that PSCs reoccupied 
synaptic sites in about eleven days (Reddy et al. 2003). One-two months after muscle 
fiber damage and X-irradiation, PSCs were ablated using 2A12 complement-mediated 
cell lysis. As in other experiments, the success of the ablation was confirmed by in vivo 
inspection of EthD staining of PSC nuclei immediately after ablation. 
 Nerve terminals were well maintained when PSCs were acutely removed from 
neuromuscular junctions without muscle fibers (Figure 7). In control PSC-ablated 
muscles, 95% of the target-deprived synaptic sites showed normal SV2 staining. In 
acute PSC-ablated muscles, only 10% of the synaptic sites without muscle fibers 
displayed mismatch between PNA and SV2 stain (Table 3). 
 One week after PSC ablation, PNA staining was weak or hardly visible at target-
removed synaptic sites, making it difficult to identify synaptic sites. Of the synaptic 
sites identified one week after PSC ablation, 6% of the synaptic sites without muscle 
fibers had mismatch between SV2 and PNA staining (n=68 neuromuscular junctions, 3 
muscles). Due to the reduced level of PNA stain, nearly all of the scored target-deprived 
and ablated synaptic sites were identified by the presence of SV2 stain; 64 of 68 
synaptic sites only had SV2 stain without visible PNA stain (Table 4 and Figure 8).   It 
is possible that nerve terminals that had retracted from ablated target-deprived synaptic 
sites were not scored due to the severe reduction in PNA stain at ablated sites. Therefore, 
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it is difficult to accurately assess the degree of nerve terminal stability in the absence of 
both PSC and target muscle fibers.   
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CHAPTER 4 
 
DISCUSSION 
 
 To the best of our knowledge, this is the first analysis of nerve terminal structure in 
the absence of both glial and target cells. This Master’s thesis investigates motor nerve 
terminals deprived of either a target muscle fiber or PSCs or both. Using microsurgery 
followed by X-irradiation, muscle fibers were permanently killed. I have determined 
that SV2 staining of motor nerve terminals is normal 1-2 months after muscle fiber 
deprivation. I also found that nerve terminals are unaltered after acute PSCs ablation. 
About 18% of the synaptic sites displayed mismatch between SV2 and PNA stain after 
one week-PSC ablation. These results were consistent with previous reports 
(Dunaevsky and Connor, 1998; Reddy et al., 2003). Ninety percent of nerve terminals 
were well maintained when PSCs are acutely removed from neuromuscular junctions 
without muscle fibers. About 6% of the target-deprived nerve terminals showed SV2 
and PNA stain mismatch after one week after PSC ablation.     
 
Role of PSCs in the maintenance of the neuromuscular junction. 
 Although PSCs are closely associated with nerve terminals, it was not until the last 
two decades that they have emerged as active and essential players in the neuromuscular 
junction. Previous studies have demonstrated that PSCs play multiple roles in the 
formation, function and repair of neuromuscular junctions (Kang and others 2003; Feng 
et al., 2005; Feng and Ko, 2007). Using FM4-64 and synapsin-1 to label nerve terminals, 
Reddy et al. have shown that less than 1% of neuromuscular junctions retracted after 
acute PSC ablation while ~13% showed partial or total retraction after one week PSC-
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ablation. Using SV2, which labels synaptic vesicles, I have found that 5% of 
neuromuscular junctions showed mismatch between PNA and SV2 stain after acute 
PSC ablation while ~18% from the one-week PSC ablated group. The variability 
between the results presented here and Reddy’s is likely due to sample size difference 
and the different immunostaining markers. When considered with the results of Reddy 
and colleagues, my results suggest that PSCs are dispensable for nerve terminal stability 
acutely but play an essential role in the long-term maintenance of neuromuscular 
junctions. The mechanism by which PSCs stabilize nerve terminals is still unclear. 
Since the remaining nerve terminals and synaptic size remained normal (Reddy et al., 
2003), it appears unlikely that PSCs stabilize nerve terminals simply via a mechanical 
glue that binds them at synaptic sites. Recently, it has been shown that Schwann cell-
conditioned medium (SC-CM) enhanced spontaneous transmitter release at developing 
neuromuscular junctions in Xenopus tissue culture (Cao and KO, 2007). It is possible 
that Schwann cell-derived functional factor(s) for the potentiation of spontaneous 
neurotransmission may also participate in the growth and maintenance of developing 
NMJs (Cao and KO, 2007). All these above-mentioned reports suggest that PSCs might 
be able to provide tropic factors to help stabilize nerve terminals. It is still necessary to 
identify these PSC-derived tropic molecules. 
 
Role of muscle fibers in the maintenance of neuromuscular junction 
 In my study, the cutaneous pectoris muscles were dissected one to two months after 
muscle damage and X-irradiation. Mismatch between nerve terminal and synaptic sites 
stains was seen at 5.2% synaptic sites. Previous work had demonstrated that 85% of 
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nerve terminals were well maintained one to two months after target removal 
(Dunaevsky and Connor, 1998). My results are consistent with that report, further 
confirming that nonmuscle factors contribute to the short-term stabilization of 
presynaptic nerve terminals. However, these results could not exclude the possible roles 
of muscle fiber in the maintenance of nerve terminals. It is possible that muscle-derived 
stabilizing molecules can persist in the synaptic basal lamina. Therefore, although 
muscle fibers are removed, these stabilizing substances might be effective for a 
relatively long period of time (i.e. one or two months) but fail eventually when not 
replaced. Muscle fibers have been shown to play an important role in the long-term 
maintenance of synaptic sites by the evidence that about 90% of the nerve terminals 
showed at least one segment retraction after 6 to 9 months of target removal 
(Dunaevsky and Connor, 1998). 
 
Removal of both muscle fiber and PSCs from neuromuscular junction 
 Acute PSC ablation one to two months after muscle fiber removal resulted in partial 
or complete loss of nerve terminals in 9.9% of the synaptic sites. So the nerve terminals 
remained stable in the absence of both PSCs and muscle fibers.  There are two main 
possible reasons for this stability. One is that some of the muscle or PSC-derived 
stabilizing molecules are deposited and stay in the basal lamina which remains at these 
synaptic sites. The other might be that basal lamina itself can provide some functional 
signals to stabilize the nerve terminals. The major and most abundant components of 
basal lamina are laminins and collagens IV (Sanes, 2003). In a recent study, presynaptic 
defects were observed in the collagen IV chains (α3-6)-deficient knockout mice, but 
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only after synapses had matured (Fox et al., 2007), demonstrating that synaptic-specific 
collagen IV chains (α3-6) are necessary for maintenance, rather than for maturation of 
nerve terminals. This strongly supports that the synaptic basal lamina most probably 
provides signals to stabilize nerve terminals, especially when PSCs and target muscle 
fibers are removed. Interestingly, presynaptic spectrin has also been found essential for 
synapse stabilization at the Drosophila neuromuscular junction (Pielage et al., 2005). 
Whether presynaptic spectrin also plays a role in the maintenance of frog 
neuromuscular junction warrants further study.  
 Even one week after PSC-ablation, only 6% of the target-deprived neuromuscular 
junctions displayed mismatch between the PNA and SV2 stains. For some unknown 
reason, PNA staining was not stable and hardly visible at most of these synaptic sites. 
Therefore, it was difficult to identify the synaptic sites and nuclei of PSCs, making it 
hard to tell whether the PSCs were successfully ablated or not. However, there is some 
evidence to support that PSCs were ablated in the selected and counted synaptic sites. 
First, the ablation of PSCs was verified on day 0 and ~95% of the PSCs were PNA- and 
EthD-positive, indicating they were ablated. Second, one week after the ablation 
process, there was EthD stain left over in some of the nuclei of PSCs (see Figure 8), 
suggesting these PSCs were EthD positive staining on day 0 and thus ablated. Finally, 
one week after ablation, most target-deprived synaptic sites showed reduced or loss of 
PNA staining. 
In practice, I located synaptic sites in the target-deprived, 1 week ablated 
preparations by the presence of SV2 stain. It is possible that synaptic sites where nerve 
terminals had retracted accompanied by loss of PNA staining were not detected and thus 
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not counted. That might be the reason why I didn’t find higher amount of nerve terminal 
retraction at the synaptic sites deprived of both PSCs and muscle fibers than those 
deprived of only one of the synaptic members, either PSC or muscle fiber. Since PSCs 
were ablated, mAb 2A12 is not a useful marker of ablated synaptic sites. Loss of PNA 
might be accelerated at target-deprived and PSC-ablated synaptic sites because PNA 
was evident with ablation in the presence of muscle fibers. More accurate data would be 
obtained if there is another more stable synaptic site maker than PNA.   
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Figure 1. Frog neuromuscular junction.  A. A motor neuron extends a myelinated axon 
to contact target skeletal muscle fibers at neuromuscular junctions.  B. In a longitudinal 
view of a frog neuromuscular junction, release domains, characterized by clusters of 
synaptic vesicles, are separated by nonrelease domains. Schwann cell cytoplasmic 
processes are occasionally found in association with nonrelease domains. 
(A: http://labs.ansci.uiuc.edu/meatscience/Library/Copy; B: Dunaevsky and Connor, 2000.) 
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Figure 2. SV2 marks frog motor nerve terminals at target-deprived synaptic sites. Triple 
labeling of a control (a-d) and one month target-deprived (e-h) synaptic sites stained 
with PNA (a, e) to mark the boundaries of synaptic sites, α-BTX (b, f) for AChRs, and 
SV2 (c, g) for nerve terminals. At the control neuromuscular junction, PNA, SV2 and 
α-BTX staining were colocalized. At the target-deprived synaptic site, α-BTX staining 
was mostly absent, indicating successful removal of the muscle fiber, while SV2 stain 
was contained within the boundaries of the PNA-marked synaptic site. Bars, 20µm. 
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Figure 3. MAb 2A12 selectively stains PSCs at frog neuromuscular junctions.  
Cutaneous pectoris muscles in whole-mount were double-stained with PNA (a, d) and 
mAb2A12 supernatant (b, e). MAb2A12 staining colocalized with PNA staining (a-c). 
In a control muscle treated with NFR and secondary antibody, mAb2A12 staining was 
not detected (d-f). Widening of mAb2A12 and PNA stains (arrow) marks the location of 
a PSC nucleus. Bars, 20µm.  
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Figure 4. Complement-mediated cell lysis with mAb 2A12 ascites results in successful 
elimination of PSCs. A neuromuscular junction from an adult frog CP was dissected 
and immunostained 3h after application of mAb 2A12 and complement. FITC-PNA 
(green) reveals the boundaries of the synaptic site and ethidium homodimer (EthD) 
labels the nuclei of dying perisynaptic Schwann cells (red). The nuclei of PSCs (arrows) 
at this synaptic site were localized at widenings in the PNA stain and were EthD 
positive, indicating the PSCs were dead. Bars, 20µm. 
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Figure 5. Nerve terminals were well maintained immediately following PSC ablation. A 
control neuromuscular junction (a-c) and a neuromuscular junction immediately after 
PSC ablation (d-f) were stained with SV2 (green) for nerve terminals, PNA (red) for 
PSCs and EthD (red) for dead PSC nuclei. At the control neuromuscular junction, PSC 
nuclei were EthD negative (arrows), indicating living PSCs. At the PSC-ablated 
neuromuscular junction, PSC nuclei were EthD positive, indicating the PSCs were 
ablated (arrow). Nerve terminals stained with SV2 appeared normal in length and 
morphology at PSC-ablated neuromuscular junctions when compared to controls. Bars, 
20µm. 
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Figure 6. A nerve terminal retracted one week after PSC ablation. Triple labeling of a 
control neuromuscular junction (a-d) and a neuromuscular junction one week after PSC 
ablation (e-h) with SV2 (green) for nerve terminals, PNA (red) for PSCs and A-tub 
(blue) for microtubules. At the control neuromuscular junction, PSC nuclei were 
Hoechst positive. At the PSC-ablated synapse, Hoechst staining was negative. SV2 
staining was normal in the control synaptic site. At the PSC-ablated site, total loss of 
SV2 and A-tub staining demonstrated the complete disappearance of a branch of the 
nerve terminal (arrows in e, f) while a neighboring site was maintained. Bars, 20µm. 
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Figure 7. Nerve terminals were well maintained in the target-deprived synaptic sites 
immediately after PSCs were ablated. Labeling of a muscle fiber-removed synaptic site 
after acute-PSC ablation with SV2 (green) for nerve terminals, PNA (red) for PSCs, 
EthD (red) for dead PSC nuclei and A-tub (blue) for microtubules. PSC nuclei were 
EthD positive, indicating the PSCs were ablated. The SV2 stain at this target-deprived 
and PSC ablated synaptic site appeared normal. Bars, 20µm. 
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Figure 8. Nerve terminals were maintained at a target-deprived synaptic site one week 
after PSCs were ablated. Labeling of a target-deprived synaptic site one week after PSC 
ablation with SV2 (green) for nerve terminals, PNA (red) for PSCs, and A-tub (blue) for 
microtubules. PNA staining was nearly invisible; SV2 and A-tub staining appeared 
normal. Upper layer: original images; lower layer: images with enhanced contrast. Bars, 
20µm. 
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Table1. Immediately following PSC ablation, nerve terminals appear normal at 
synaptic sites in the presence of muscle fibers. 
 
Preparation # Muscles # Synaptic 
sites 
# Synaptic sites with 
SV2 and PNA stain 
mismatch 
% Synaptic sites with 
SV2 and PNA stain 
mismatch 
Ablation 
control 2 203 0 0% 
Acute PSC-
ablated 4 121 6 5% 
 
 
Table 2. Alteration in the morphology of nerve terminals at control and one 
week  PSC-ablated synaptic sites. 
 
Preparation # Muscles # Synaptic 
sites 
# Synaptic sites with 
SV2 and PNA stain 
mismatch 
% Synaptic sites with 
SV2 and PNA stain 
mismatch  
Ablation 
control 2 141 5 3.5% 
One week 
PSC-ablated 10 285 52 18.2% 
 
 
Table 3. Morphology of nerve terminals at target-deprived synaptic sites after 
control or acute PSC ablation 
 
Preparation # Muscles # Synaptic 
sites 
# Synaptic sites with 
SV2 and PNA stain 
mismatch 
% Synaptic sites 
with SV2 and PNA 
stain mismatch  
Target-deprived 
Ablation control 4 96 5 5.2% 
Target-deprived 
Acute PSC ablation 8 141 14 9.9% 
 
 
Table 4. Some nerve terminals were maintained at target-deprived synaptic sites 
one week after PSCs were ablated. 
 
Preparation # Muscles # Synaptic 
sites 
# Synaptic sites with 
SV2 and PNA stain 
mismatch 
% Synaptic sites 
with SV2 and PNA 
stain mismatch  
Target-deprived 
One week PSC-ablated 3 68 4 5.88% 
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